Brief: Oruka Therapeutics Announces Positive Interim Phase 1 Results For Orka-001
17/09/2025 06:01
Sept 17 (Reuters) - Oruka Therapeutics Inc ORKA.O: ORUKA THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE 1 RESULTS FOR ORKA-001 Source text: ID:nGNX3ZC4Ww Further company coverage: ORKA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary